{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:14:51Z","timestamp":1778739291489,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.urolonc.2014.09.016","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T20:48:06Z","timestamp":1418158086000},"page":"110.e19-110.e27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells"],"prefix":"10.1016","volume":"33","author":[{"given":"Peter J.","family":"Olbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Kesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Henrici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentine S.","family":"Subtil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Honacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"H\u00e4nze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2014.09.016_bib1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update","volume":"59","author":"Babjuk","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2014.09.016_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1189\/jlb.0103026","article-title":"TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG","volume":"74","author":"Heldwein","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.urolonc.2014.09.016_bib3","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1128\/IAI.68.12.6883-6890.2000","article-title":"Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors","volume":"68","author":"Tsuji","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.urolonc.2014.09.016_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.imbio.2006.05.004","article-title":"Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guerin by Flt3-ligand generated dendritic cells","volume":"211","author":"von Meyenn","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.urolonc.2014.09.016_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.2007.06802.x","article-title":"Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis","volume":"139","author":"McGettrick","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.urolonc.2014.09.016_bib6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0952-7915(03)00080-3","article-title":"Recognition of microbial infection by toll-like receptors","volume":"15","author":"Kopp","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.urolonc.2014.09.016_bib7","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.4049\/jimmunol.173.9.5398","article-title":"Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells","volume":"173","author":"Vora","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.urolonc.2014.09.016_bib8","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00262-008-0459-8","article-title":"Toll-like receptors expressed in tumor cells: targets for therapy","volume":"57","author":"Yu","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.urolonc.2014.09.016_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/41131","article-title":"A human homologue of the Drosophila Toll protein signals activation of adaptive immunity","volume":"388","author":"Medzhitov","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2014.09.016_bib10","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene","volume":"282","author":"Poltorak","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2014.09.016_bib11","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.1158\/0008-5472.CAN-07-0079","article-title":"Activation of toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo","volume":"67","author":"Andreani","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2014.09.016_bib12","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.molimm.2007.01.022","article-title":"TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance","volume":"44","author":"He","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.urolonc.2014.09.016_bib13","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1158\/0008-5472.CAN-05-0784","article-title":"Toll-like receptors on tumor cells facilitate evasion of immune surveillance","volume":"65","author":"Huang","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2014.09.016_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1741-7015-10-98","article-title":"Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide","volume":"10","author":"Jing","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.urolonc.2014.09.016_bib15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11912-004-0019-0","article-title":"Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides","volume":"6","author":"Krieg","year":"2004","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.urolonc.2014.09.016_bib16","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2014.09.016_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/eji.200324032","article-title":"Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities","volume":"34","author":"Vollmer","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.urolonc.2014.09.016_bib18","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1158\/1541-7786.MCR-07-2005","article-title":"Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion","volume":"6","author":"Ilvesaro","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.urolonc.2014.09.016_bib19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/pros.20562","article-title":"Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro","volume":"67","author":"Ilvesaro","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2014.09.016_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1158\/1541-7786.MCR-06-0007","article-title":"Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity","volume":"4","author":"Merrell","year":"2006","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.urolonc.2014.09.016_bib21","first-page":"805","article-title":"Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas","volume":"37","author":"Tanaka","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.urolonc.2014.09.016_bib22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/1471-2407-10-415","article-title":"TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients","volume":"10","author":"Wang","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2014.09.016_bib23","first-page":"2225","article-title":"Antineoplastic effect of immunostimulatory DNA (CpG-ODN) in a murine C57-BL6\/MB-49 transitional cell carcinoma model","volume":"24","author":"Hegele","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2014.09.016_bib24","first-page":"2067","article-title":"In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall","volume":"29","author":"Olbert","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2014.09.016_bib25","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.juro.2010.12.097","article-title":"Toll-like receptors in normal and malignant human bladders","volume":"185","author":"Ayari","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2014.09.016_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<149::AID-IJC21>3.0.CO;2-D","article-title":"Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro","volume":"72","author":"Okamoto","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2014.09.016_bib27","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ejca.2006.01.012","article-title":"Tumour necrosis factor-alpha as a tumour promoter","volume":"42","author":"Szlosarek","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2014.09.016_bib28","doi-asserted-by":"crossref","first-page":"12468","DOI":"10.1073\/pnas.0705226104","article-title":"TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts","volume":"104","author":"Damiano","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2014.09.016_bib29","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1016\/j.yexcr.2010.05.024","article-title":"Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13","volume":"316","author":"Nurmenniemi","year":"2010","journal-title":"Exp Cell Res"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143914003366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143914003366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:03:55Z","timestamp":1761041035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143914003366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1078143914003366"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2014.09.016","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2014.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}